52 results
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
under Form S-8 promulgated under the Securities Act.
(l) “Director” means a member of the Board.
(m) “Disability” means total and permanent … disability, as determined by the Administrator in its discretion in accordance with uniform and non-discriminatory standards adopted by the Administrator from
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
with PWS function in the mild intellectual disability range with a mean IQ in the 60s to low 70s. The combination of food-related preoccupations … disability range with a mean IQ in the 60s to low 70s. The combination of food-related preoccupations and numerous maladaptive behaviors make it difficult
424B5
syyskb8
27 Sep 23
Prospectus supplement for primary offering
5:26pm
424B5
3otuu99
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
ibbbyrg0isq9pham6
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
msl1u5
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-10.3
fzqtnx88
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
svh0mkbfplfcnt 0ym
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-10.1
5vfo6g wz70u6q
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
27z6y3xpccz39kv8p
26 Jun 20
Registration of securities for employees
5:01pm
424B5
twr5j8sidjnpjr0byt
25 Jun 20
Prospectus supplement for primary offering
4:01pm